Please ensure Javascript is enabled for purposes of website accessibility Asia Equity Fund - Janus Henderson Investors
For Individual Investors in the US

Asia Equity Fund Holdings

Full Portfolio Holdings

(As of April 30, 2024)

% OF INVESTMENTS
Taiwan Semiconductor Manufacturing Co Ltd 9.32
Samsung Electronics Co Ltd 8.70
HDFC Bank Ltd 4.66
AIA Group Ltd 4.64
Bharti Airtel Ltd 3.72
Tencent Holdings Ltd 3.57
Full Truck Alliance Co Ltd (ADR) 3.05
ICICI Bank Ltd 2.99
BYD Co Ltd 2.92
H World Group Ltd 2.65
KB Financial Group Inc 2.32
Eicher Motors Ltd 2.30
Contemporary Amperex Technology Co Ltd 2.19
Accton Technology Corp 2.19
Vietnam Technological & Commercial Joint Stock Bank 2.01
HDFC Life Insurance Co Ltd 1.98
Sea Ltd (ADR) 1.93
SK Hynix Inc 1.86
BDO Unibank Inc 1.76
New Horizon Health Ltd 1.63
Hana Financial Group Inc 1.60
EPL Ltd 1.57
BGF retail Co Ltd 1.49
NAVER Corp 1.40
ZJLD Group Inc 1.38
Sinbon Electronics Co Ltd 1.38
Angelalign Technology Inc 1.34
Ace Hardware Indonesia Tbk PT 1.34
Shenzhen Inovance Technology Co Ltd 1.32
Zai Lab Ltd 1.32
Shenzhen Mindray Bio-Medical Electronics Co Ltd 1.32
Hong Kong Exchanges & Clearing Ltd 1.31
International Container Terminal Services Inc 1.31
MakeMyTrip Ltd 1.28
Hyundai Motor Co 1.27
Syngene International Ltd 1.26
ASMPT Ltd 1.22
Structure Therapeutics Inc (ADR) 1.11
StarPower Semiconductor Ltd 0.96
Kalyan Jewellers India Ltd 0.88
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 0.87
Legend Biotech Corp (ADR) 0.87
E Ink Holdings Inc 0.84
Chroma ATE Inc 0.77
KEI Industries Ltd 0.75
TechWing Inc 0.56
Park Systems Corp 0.41
Cash & Equivalents 2.48
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.